Table 1 Clinical characteristics of the study subjects (n = 86)
No. (%) | |
|---|---|
Tumor site | |
Rectum | 19 (22.1%) |
Colon | 64 (74.4%) |
Caecum | 24 (27.9%) |
Ascending colon | 16 (18.6%) |
Hepatic flexure | 4 (4.7%) |
Transverse colon | 9 (10.5%) |
Splenic flexure | 4 (4.7%) |
Descending colon | 7 (8%) |
Rectosigmoid | 3 (3.5%) |
Tumor grade | |
Low | 17 (19.8%) |
Intermediate | 59 (68.6%) |
High | 10 (11.6%) |
Min.–Max | 1.0–3.0 |
Median (IQR) | 2 (1.0–3.0) |
Dukes stage | |
B | 1 (1.2%) |
C | 2 (2.3%) |
D | 83 (96.5%) |
Min.–Max | 2.0–4.0 |
Median (IQR) | 4.0 (2.0–4.0) |